Zurich Cantonal Bank’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-43,784
| Closed | -$46K | – | 2707 |
|
|
2023
Q4 | $46K | Buy |
43,784
+23,467
| +116% | +$24.6K | ﹤0.01% | 2610 |
|
|
2023
Q3 | $139K | Buy |
20,317
+6,074
| +43% | +$41.6K | ﹤0.01% | 2187 |
|
|
2023
Q2 | $148K | Buy |
14,243
+4,484
| +46% | +$46.5K | ﹤0.01% | 2115 |
|
|
2023
Q1 | $79K | Hold |
9,759
| – | – | ﹤0.01% | 2421 |
|
|
2022
Q4 | $154K | Buy |
9,759
+2,258
| +30% | +$35.6K | ﹤0.01% | 1987 |
|
|
2022
Q3 | $118K | Hold |
7,501
| – | – | ﹤0.01% | 2086 |
|
|
2022
Q2 | $105K | Hold |
7,501
| – | – | ﹤0.01% | 2198 |
|
|
2022
Q1 | $129K | Hold |
7,501
| – | – | ﹤0.01% | 2152 |
|
|
2021
Q4 | $109K | Buy |
7,501
+4,290
| +134% | +$62.3K | ﹤0.01% | 2463 |
|
|
2021
Q3 | $58K | Buy |
+3,211
| New | +$58K | ﹤0.01% | 2574 |
|
|
2019
Q2 | – | Sell |
-1,818
| Closed | -$11K | – | 2614 |
|
|
2019
Q1 | $11K | Hold |
1,818
| – | – | ﹤0.01% | 2503 |
|
|
2018
Q4 | $13K | Hold |
1,818
| – | – | ﹤0.01% | 2521 |
|
|
2018
Q3 | $26K | Hold |
1,818
| – | – | ﹤0.01% | 2412 |
|
|
2018
Q2 | $36K | Hold |
1,818
| – | – | ﹤0.01% | 2285 |
|
|
2018
Q1 | $32K | Hold |
1,818
| – | – | ﹤0.01% | 2280 |
|
|
2017
Q4 | $45K | Buy |
1,818
+517
| +40% | +$12.8K | ﹤0.01% | 2131 |
|
|
2017
Q3 | $34K | Hold |
1,301
| – | – | ﹤0.01% | 2027 |
|
|
2017
Q2 | $35K | Sell |
1,301
-3,500
| -73% | -$94.2K | ﹤0.01% | 1970 |
|
|
2017
Q1 | $143K | Buy |
4,801
+3,500
| +269% | +$104K | ﹤0.01% | 1135 |
|
|
2016
Q4 | $35K | Buy |
+1,301
| New | +$35K | ﹤0.01% | 1932 |
|